{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:01:56Z","timestamp":1773421316088,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/eurheartj\/ehi287","type":"journal-article","created":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T00:13:49Z","timestamp":1114733629000},"page":"1846-1851","source":"Crossref","is-referenced-by-count":73,"title":["Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events"],"prefix":"10.1093","volume":"26","author":[{"given":"Tanja K.","family":"Krempl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renke","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Sydow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meinertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer H.","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"K\u00e4hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,28]]},"reference":[{"key":"key\n\t\t\t\t20171011182559_EHI287C1","doi-asserted-by":"crossref","unstructured":"Vallance P, Leone AM, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthase. J Cardiovasc Pharmacol1992;20(Suppl. 12):560\u2013562.","DOI":"10.1097\/00005344-199204002-00018"},{"key":"key\n\t\t\t\t20171011182559_EHI287C2","doi-asserted-by":"crossref","unstructured":"Clarke S. Protein methylation. Curr Opin Cell Biol1993;5:977\u2013983.","DOI":"10.1016\/0955-0674(93)90080-A"},{"key":"key\n\t\t\t\t20171011182559_EHI287C3","doi-asserted-by":"crossref","unstructured":"McBride AE, Silver PA. State of Arg: protein methylation at arginine comes to age. Cell2001;106:5\u20138.","DOI":"10.1016\/S0092-8674(01)00423-8"},{"key":"key\n\t\t\t\t20171011182559_EHI287C4","doi-asserted-by":"crossref","unstructured":"Ogawa T, Kimoto M, Sasaoka K. Occurrence of a new enzyme catalyzing the direct conversion of NG, NG-dimethyl-L-arginine to L-citrulline in rats. Biochem Biophys Res Commun1987;148:671\u2013677.","DOI":"10.1016\/0006-291X(87)90929-6"},{"key":"key\n\t\t\t\t20171011182559_EHI287C5","doi-asserted-by":"crossref","unstructured":"Kimoto M, Whitley GS, Tsuji H, Ogawa T. Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo)1995;117:237\u2013238.","DOI":"10.1093\/jb\/117.2.237"},{"key":"key\n\t\t\t\t20171011182559_EHI287C6","doi-asserted-by":"crossref","unstructured":"Cooke JP. Asymmetrical dimethylarginine. The \u00fcber marker? Circulation2004;109:1813\u20131819.","DOI":"10.1161\/01.CIR.0000126823.07732.D5"},{"key":"key\n\t\t\t\t20171011182559_EHI287C7","doi-asserted-by":"crossref","unstructured":"Kubes P, Suzuki M, Ganger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA1991;88:4651\u20134655.","DOI":"10.1073\/pnas.88.11.4651"},{"key":"key\n\t\t\t\t20171011182559_EHI287C8","doi-asserted-by":"crossref","unstructured":"Garg UC, Hassid A. Nitric oxide-generating vasodilatators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest1989;83:1774\u20131777.","DOI":"10.1172\/JCI114081"},{"key":"key\n\t\t\t\t20171011182559_EHI287C9","doi-asserted-by":"crossref","unstructured":"Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet1987;2:1057\u20131058.","DOI":"10.1016\/S0140-6736(87)91481-4"},{"key":"key\n\t\t\t\t20171011182559_EHI287C10","doi-asserted-by":"crossref","unstructured":"Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured smooth muscle cells. Circ Res1996;78:225\u2013230.","DOI":"10.1161\/01.RES.78.2.225"},{"key":"key\n\t\t\t\t20171011182559_EHI287C11","doi-asserted-by":"crossref","unstructured":"B\u00f6ger RH, Bode-B\u00f6ger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation1998;98:1842\u20131847.","DOI":"10.1161\/01.CIR.98.18.1842"},{"key":"key\n\t\t\t\t20171011182559_EHI287C12","doi-asserted-by":"crossref","unstructured":"Surdacki A, Nowicki M, Sandmann J, Tsikas PS, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol1999;33:652\u2013658.","DOI":"10.1097\/00005344-199904000-00020"},{"key":"key\n\t\t\t\t20171011182559_EHI287C13","doi-asserted-by":"crossref","unstructured":"Abbasi F, Asagmi T, Cooke JP, Lamendola C, KcLaughlin T, Reaven GM, Stuehlinger M, Tsao PS. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol2001;88:1201\u20131203.","DOI":"10.1016\/S0002-9149(01)02063-X"},{"key":"key\n\t\t\t\t20171011182559_EHI287C14","doi-asserted-by":"crossref","unstructured":"Zoccali C, Bode-B\u00f6ger SM, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Catalotti A, Bellanuova I, Fermo I, Froelich J, B\u00f6ger RH. Plasma concentrations of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet2001;358:2113\u20132117.","DOI":"10.1016\/S0140-6736(01)07217-8"},{"key":"key\n\t\t\t\t20171011182559_EHI287C15","doi-asserted-by":"crossref","unstructured":"Valkonen VP, P\u00e4lv\u00e4 H, Salonen JT, Lakka TA, Lektimaki T, Laaks J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet2001;358:2127\u20132128.","DOI":"10.1016\/S0140-6736(01)07184-7"},{"key":"key\n\t\t\t\t20171011182559_EHI287C16","doi-asserted-by":"crossref","unstructured":"Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J2003;24:1912\u20131919.","DOI":"10.1016\/j.ehj.2003.08.013"},{"key":"key\n\t\t\t\t20171011182559_EHI287C17","unstructured":"Norman, Streiner. Biostatistics. Hamilton, London: B.C. Becker Inc.; 2000. p300 (Table\u00a0D)."},{"key":"key\n\t\t\t\t20171011182559_EHI287C18","doi-asserted-by":"crossref","unstructured":"Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, B\u00f6ger RH. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med2004;42:1377\u20131383.","DOI":"10.1515\/CCLM.2004.257"},{"key":"key\n\t\t\t\t20171011182559_EHI287C19","doi-asserted-by":"crossref","unstructured":"McMurry J, Chopra M, Abdullah I, Smith WE, Dargei HJ. Evidence of oxidative stress in unstable angina. Br Heart J1992;68:454\u2013457.","DOI":"10.1136\/hrt.68.11.454"},{"key":"key\n\t\t\t\t20171011182559_EHI287C20","doi-asserted-by":"crossref","unstructured":"Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L, Brunsvig A. Muller F, Forfang K, Froland K, Gulestad L. Interactions between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol2001;37:485\u2013491.","DOI":"10.1016\/S0735-1097(00)01110-4"},{"key":"key\n\t\t\t\t20171011182559_EHI287C21","doi-asserted-by":"crossref","unstructured":"Yokoyama M. Oxidant stress and atherosclerosis. Curr Opin Pharmacol2004;4:110\u2013115.","DOI":"10.1016\/j.coph.2003.12.004"},{"key":"key\n\t\t\t\t20171011182559_EHI287C22","doi-asserted-by":"crossref","unstructured":"Valgimigli M, Merli E, Malagutti P, Soukhomovskaia O, Cicchitelli G, Macri G, Ferrari R. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. Arch Biochem Biophys2003;420:255\u2013261.","DOI":"10.1016\/j.abb.2003.07.006"},{"key":"key\n\t\t\t\t20171011182559_EHI287C23","doi-asserted-by":"crossref","unstructured":"Sydow K, M\u00fcnzel T. ADMA and oxidative stress. Atheroscler Suppl2003;4:41\u201351.","DOI":"10.1016\/S1567-5688(03)00033-3"},{"key":"key\n\t\t\t\t20171011182559_EHI287C24","doi-asserted-by":"crossref","unstructured":"B\u00f6ger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas PS, Bode-B\u00f6ger SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res2000;87:99\u2013105.","DOI":"10.1161\/01.RES.87.2.99"},{"key":"key\n\t\t\t\t20171011182559_EHI287C25","doi-asserted-by":"crossref","unstructured":"Wada K, Inoue K, Hagiwara M. Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy. Biochem Biophys Acta2002;1591:1\u201310.","DOI":"10.1016\/S0167-4889(02)00202-1"},{"key":"key\n\t\t\t\t20171011182559_EHI287C26","doi-asserted-by":"crossref","unstructured":"Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol2004;24:1023\u20131030.","DOI":"10.1161\/01.ATV.0000128897.54893.26"},{"key":"key\n\t\t\t\t20171011182559_EHI287C27","doi-asserted-by":"crossref","unstructured":"Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation1999;99:3092\u20133095.","DOI":"10.1161\/01.CIR.99.24.3092"},{"key":"key\n\t\t\t\t20171011182559_EHI287C28","doi-asserted-by":"crossref","unstructured":"Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, Cooke JP. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis. Circulation2003;108:3042\u20133047.","DOI":"10.1161\/01.CIR.0000101924.04515.2E"},{"key":"key\n\t\t\t\t20171011182559_EHI287C29","doi-asserted-by":"crossref","unstructured":"Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA2002;99:13527\u201313532.","DOI":"10.1073\/pnas.212269799"},{"key":"key\n\t\t\t\t20171011182559_EHI287C30","doi-asserted-by":"crossref","unstructured":"Zoccali C, Benedetto A, Maas R, Mallamaci F, Tripepi G, Malatino L, B\u00f6ger R. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-medi thickness in end-stage renal failure. J Am Soc Nephrol2002;13:490\u2013496.","DOI":"10.1681\/ASN.V132490"},{"key":"key\n\t\t\t\t20171011182559_EHI287C31","doi-asserted-by":"crossref","unstructured":"George J, Shmuel SB, Roth A, Herz I, Izraelov S, Deutsch V, Keren G, Miller H. L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty. Atherosclerosis2004;174:323\u2013327.","DOI":"10.1016\/j.atherosclerosis.2004.01.025"},{"key":"key\n\t\t\t\t20171011182559_EHI287C32","doi-asserted-by":"crossref","unstructured":"Walker HA, McGing E, Fisher I, B\u00f6ger RH, Bode-B\u00f6ger SM, Jackson G, Ritter JM, Chowienczyk PJ. Endothelium-dependent vasodilation is independent of the plasma L-arginine\/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol2001;38:499\u2013505.","DOI":"10.1016\/S0735-1097(01)01380-8"},{"key":"key\n\t\t\t\t20171011182559_EHI287C33","doi-asserted-by":"crossref","unstructured":"Tsikas D, B\u00f6ger RH, Sandmann J, Bode-B\u00f6ger SM, Fr\u00f6lich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett2000;478:1\u20133.","DOI":"10.1016\/S0014-5793(00)01686-0"},{"key":"key\n\t\t\t\t20171011182559_EHI287C34","doi-asserted-by":"crossref","unstructured":"B\u00f6ger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res2003;59:824\u2013833.","DOI":"10.1016\/S0008-6363(03)00500-5"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/18\/1846\/5963564\/ehi287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T04:55:48Z","timestamp":1625892948000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/18\/1846\/406486\/Elevation-of-asymmetric-dimethylarginine-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,28]]},"references-count":34,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2005,4,28]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi287","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,4,28]]}}}